Inflarx NV (IFRX) is near the bottom in its industry group according to InvestorsObserver. IFRX gets an overall rating of 32. That means it scores higher than 32 percent of stocks. Inflarx NV gets a 18 rank in the Biotechnology industry. Biotechnology is number 84 out of 148 industries.
Click Here to get the full Stock Score Report on Inflarx NV (IFRX) Stock.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 32 means the stock is more attractive than 32 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Inflarx NV Stock Today?
Inflarx NV (IFRX) stock is higher by 1.73% while the S&P 500 is down -0.23% as of 11:00 AM on Friday, Nov 29. IFRX has risen $0.06 from the previous closing price of $3.47 on volume of 881,155 shares. Over the past year the S&P 500 has risen 14.93% while IFRX is down -88.36%. IFRX lost -$2.11 per share the over the last 12 months.
